Galveston, TX, United States of America

Roberto P Garofalo

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: The University of Texas System. Active years: 2004-2017.

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 72(Granted Patents)


Company Filing History:


Years Active: 2004-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Roberto P. Garofalo

Introduction

Roberto P. Garofalo is a notable inventor based in Galveston, Texas. He has made significant contributions to the field of medical research, particularly in the treatment of viral infections. With a total of 3 patents to his name, Garofalo's work is recognized for its innovative approaches to healthcare.

Latest Patents

Garofalo's latest patents focus on methods for treating viral infections using hydrogen sulfide donors. Certain embodiments of these patents are directed to methods of treating respiratory infections by administering an HS donor. This innovative approach highlights his commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Garofalo is affiliated with the University of Texas System, where he continues to engage in groundbreaking research. His work has garnered attention for its potential to revolutionize the way viral infections are treated, showcasing his expertise and dedication to the field.

Collaborations

Some of his notable coworkers include Antonella Casola and Alexander N. Freiberg. Their collaborative efforts contribute to the advancement of research in viral infections and enhance the impact of their collective work.

Conclusion

Roberto P. Garofalo's innovative contributions to medical research, particularly in the treatment of viral infections, underscore his importance as an inventor. His patents and collaborations reflect a commitment to improving healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…